Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|January 21, 2022
Lymphoblastic Lymphoma: a Concise ReviewTamara Intermesoli, Alessandra Weber, Matteo Leoncin, et al.
Current Opinion in Oncology|August 26, 2022
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicineMatteo Leoncin, Roberta La Starza, Giovanni Roti, et al.
Frontiers in Oncology|April 29, 2024
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experienceFrancesco Angotzi, Federica Lessi, Matteo Leoncin, et al.
Haematologica|August 31, 2019
Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemiaBarbara Mariotti, Giulia Calabretto, Marzia Rossato, et al.
Leukemia|November 20, 2019
Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patientsGregorio Barilà, Antonella Teramo, Giulia Calabretto, et al.
Cancers|April 30, 2021
MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALLManuela Tosi, Orietta Spinelli, Matteo Leoncin, et al.
Clinical Case Reports|January 14, 2022
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemiaGiuliana Rizzuto, Matteo Leoncin, Silvia Imbergamo, et al.
Leukemia Research|February 12, 2022
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experienceEleonora De Bellis, Silvia Imbergamo, Anna Candoni, et al.
Oncotarget|October 6, 2017
STAT3 mutation impacts biological and clinical features of T-LGL leukemiaAntonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Annals of Hematology|March 24, 2023
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL studyDavide Lazzarotto, Ilaria Tanasi, Antonella Vitale, et al.
Pageof 2